Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000509359 | SCV001528231 | uncertain significance | Phosphoenolpyruvate carboxykinase deficiency, mitochondrial | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV002060174 | SCV002473773 | likely benign | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Genome |
RCV000509359 | SCV000607049 | not provided | Phosphoenolpyruvate carboxykinase deficiency, mitochondrial | no assertion provided | phenotyping only | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Prevention |
RCV004755943 | SCV005346382 | likely benign | PCK2-related disorder | 2024-07-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |